Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anca M Avram

Showing results (51-60 of 74) with videos related to

Pageof 8
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 23, 2019
The Martinique PrinciplesSukhjeet Ahuja, Anca M Avram, Gary Dillehay, et al.
The Journal of Clinical Endocrinology and Metabolism|December 29, 2012
Residual thyroid tissue after thyroidectomy in a patient with TSH receptor-activating mutation presenting as a neck massKanakadurga Singer, Ram K Menon, Marci M Lesperance, et al.
Clinical Nuclear Medicine|December 16, 2010
Comparison of single time-point [111-In] pentetreotide SPECT/CT with dual time-point imaging of neuroendocrine tumorsKa Kit Wong, Elizabeth A Wynn, Jamie Myles, et al.
Radiographics : a Review Publication of the Radiological Society of North America, Inc|March 13, 2013
SPECT/CT evaluation of unusual physiologic radioiodine biodistributions: pearls and pitfalls in image interpretationDaniel I Glazer, Richard K J Brown, Ka Kit Wong, et al.
Cancer Biotherapy & Radiopharmaceuticals|October 10, 2013
Biological-effect modeling of radioimmunotherapy for non-hodgkins lymphoma: determination of model parametersPeter L Roberson, Scott J Wilderman, Anca M Avram, et al.
Clinical Nuclear Medicine|October 30, 2018
Differentiated Thyroid Cancer Outcomes After Surgery and Activity-Adjusted 131I TheragnosticsAnca M Avram, Natalja Rosculet, Nazanene H Esfandiari, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 22, 2010
Bio-effect model applied to 131I radioimmunotherapy of refractory non-Hodgkin's lymphomaPeter L Roberson, Hanan Amro, Scott J Wilderman, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 3, 2023
The EANM guideline on radioiodine therapy of benign thyroid diseaseAlfredo Campennì, Anca M Avram, Frederik A Verburg, et al.
Clinical Endocrinology|May 9, 2019
The Clinical Impact of [<sup>68</sup> Ga]-DOTATATE PET/CT for the Diagnosis and Management of Ectopic Adrenocorticotropic Hormone - Secreting TumoursTaweesak Wannachalee, Adina F Turcu, Irina Bancos, et al.
Thyroid : Official Journal of the American Thyroid Association|March 23, 2018
Location and Causation of Residual Lymph Node Metastasis After Surgical Treatment of Regionally Advanced Differentiated Thyroid CancerJessa E Miller, Neal C Al-Attar, Owen H Brown, et al.
Pageof 8

Showing results (51-60 of 74) with videos related to

Sort By:
Pageof 8
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 23, 2019
The Martinique PrinciplesSukhjeet Ahuja, Anca M Avram, Gary Dillehay, et al.
The Journal of Clinical Endocrinology and Metabolism|December 29, 2012
Residual thyroid tissue after thyroidectomy in a patient with TSH receptor-activating mutation presenting as a neck massKanakadurga Singer, Ram K Menon, Marci M Lesperance, et al.
Clinical Nuclear Medicine|December 16, 2010
Comparison of single time-point [111-In] pentetreotide SPECT/CT with dual time-point imaging of neuroendocrine tumorsKa Kit Wong, Elizabeth A Wynn, Jamie Myles, et al.
Radiographics : a Review Publication of the Radiological Society of North America, Inc|March 13, 2013
SPECT/CT evaluation of unusual physiologic radioiodine biodistributions: pearls and pitfalls in image interpretationDaniel I Glazer, Richard K J Brown, Ka Kit Wong, et al.
Cancer Biotherapy & Radiopharmaceuticals|October 10, 2013
Biological-effect modeling of radioimmunotherapy for non-hodgkins lymphoma: determination of model parametersPeter L Roberson, Scott J Wilderman, Anca M Avram, et al.
Clinical Nuclear Medicine|October 30, 2018
Differentiated Thyroid Cancer Outcomes After Surgery and Activity-Adjusted 131I TheragnosticsAnca M Avram, Natalja Rosculet, Nazanene H Esfandiari, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 22, 2010
Bio-effect model applied to 131I radioimmunotherapy of refractory non-Hodgkin's lymphomaPeter L Roberson, Hanan Amro, Scott J Wilderman, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 3, 2023
The EANM guideline on radioiodine therapy of benign thyroid diseaseAlfredo Campennì, Anca M Avram, Frederik A Verburg, et al.
Clinical Endocrinology|May 9, 2019
The Clinical Impact of [<sup>68</sup> Ga]-DOTATATE PET/CT for the Diagnosis and Management of Ectopic Adrenocorticotropic Hormone - Secreting TumoursTaweesak Wannachalee, Adina F Turcu, Irina Bancos, et al.
Thyroid : Official Journal of the American Thyroid Association|March 23, 2018
Location and Causation of Residual Lymph Node Metastasis After Surgical Treatment of Regionally Advanced Differentiated Thyroid CancerJessa E Miller, Neal C Al-Attar, Owen H Brown, et al.
Pageof 8